Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121740) titled 'A randomized, double-blind, placebo-controlled, multicenter clinical trial on the efficacy and safety of Xiaoyu Jiangzhi capsule in improving inflammatory markers in patients with chronic coronary syndrome' on April 2.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai East Hospital
Condition:
Chronic Coronary syndrome (CCS)
Intervention:
Experimental Group:Xiaoyu Jiangzhi capsule
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-11-04
Target Sample Size: Experimental Group:60;Control group:60;
Countries of Recruitment:
China
To know more, visi...